TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 2.791
AS - Asia 1.737
EU - Europa 1.477
SA - Sud America 401
AF - Africa 47
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.457
Nazione #
US - Stati Uniti d'America 2.712
SG - Singapore 756
CN - Cina 416
IT - Italia 332
BR - Brasile 318
RU - Federazione Russa 266
DE - Germania 262
HK - Hong Kong 240
IE - Irlanda 197
SE - Svezia 128
VN - Vietnam 122
GB - Regno Unito 56
CA - Canada 47
FI - Finlandia 44
AT - Austria 41
AR - Argentina 31
IN - India 30
FR - Francia 26
KR - Corea 26
UA - Ucraina 26
TR - Turchia 25
ZA - Sudafrica 24
JP - Giappone 22
NL - Olanda 22
ID - Indonesia 21
MX - Messico 21
PL - Polonia 20
EC - Ecuador 19
BD - Bangladesh 18
ES - Italia 18
EG - Egitto 12
PK - Pakistan 12
DK - Danimarca 11
CL - Cile 9
IQ - Iraq 9
CO - Colombia 6
IL - Israele 6
IR - Iran 6
LT - Lituania 6
PY - Paraguay 6
UZ - Uzbekistan 6
AL - Albania 5
SA - Arabia Saudita 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
JO - Giordania 4
PH - Filippine 4
AU - Australia 3
BE - Belgio 3
MA - Marocco 3
PE - Perù 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.457
Città #
Ann Arbor 509
Singapore 474
Ashburn 286
Hong Kong 240
Chandler 196
Dublin 192
Frankfurt am Main 185
Woodbridge 167
Fairfield 129
New York 92
Wilmington 90
Beijing 88
Dallas 84
Los Angeles 70
Milan 68
Hefei 58
Houston 52
Seattle 50
Princeton 48
Shanghai 48
Santa Clara 43
The Dalles 42
Cambridge 41
Jacksonville 40
Ho Chi Minh City 39
Hanoi 34
Lissone 34
São Paulo 34
Moscow 33
Munich 33
Dearborn 30
Vienna 29
Seoul 26
Buffalo 25
Altamura 23
Lawrence 22
Chicago 21
Tokyo 18
Jakarta 17
Nanjing 17
Turku 17
Warsaw 17
Brooklyn 16
London 14
Montreal 13
Nuremberg 13
Johannesburg 12
Helsinki 11
Lachine 11
Ottawa 11
Columbus 10
Rio de Janeiro 10
Rome 10
San Diego 10
Andover 9
Boardman 9
Caronno Pertusella 9
Denver 9
Orem 9
Toronto 9
Brasília 8
Hangzhou 8
Mexico City 8
Phoenix 8
Xi'an 8
Belo Horizonte 7
Campinas 7
Changsha 7
Chennai 7
Curitiba 7
Guangzhou 7
Pavia 7
San Francisco 7
San Jose 7
Shenyang 7
Stockholm 7
Alexandria 6
Cape Town 6
Charlotte 6
Jinan 6
Melzo 6
Quito 6
Roubaix 6
Tashkent 6
Bologna 5
Boston 5
Council Bluffs 5
Detroit 5
Florence 5
Kent 5
Lahore 5
Lappeenranta 5
Poplar 5
Pune 5
Salt Lake City 5
Santo André 5
Tampa 5
Tel Aviv 5
Tirana 5
Ankara 4
Totale 4.200
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 304
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 303
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 271
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 263
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 244
Neutrophil Extracellular Traps in the Autoimmunity Context 240
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 230
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 229
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 226
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 223
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 219
Novel Therapies in Takayasu Arteritis 215
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 207
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 192
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 189
Immunology of membranous nephropathy: From animal models to humans 186
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 185
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 179
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 172
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 169
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 166
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 165
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 163
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 162
Evidence for charge-based mimicry in anti dsDNA antibody generation 160
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 159
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 155
ANCA-associated vasculitides (AAV) from the gender point of view 153
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 147
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 137
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 135
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 133
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 120
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 117
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 94
Totale 6.612
Categoria #
all - tutte 22.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021412 0 0 0 0 0 65 76 41 52 75 44 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20261.989 442 208 305 406 455 173 0 0 0 0 0 0
Totale 6.612